BookFred A. Mettler Jr., Milton J. Guiberteau.
Contents:
Radioactivity, radionuclides, and radiopharmaceuticals
Instrumentation and quality control
Central nervous system
Thyroid, parathyroid, and salivary glands
Cardiovascular system
Respiratory system
Gastrointestinal tract
Skeletal system
Genitourinary system and adrenal glands
Non-PET neoplasm imaging and radioimmunotherapy
¹⁸F-FDG PET/CT neoplasm imaging
Inflammation and infection imaging
Authorized user and radioisotope safety issues
Self-evaluation. Unknown case sets
Answers to unknown case sets
Appendix A: Characteristics of radionuclides for imaging and therapy
Appendix B-1: Radioactivity conversion table for International System (SI) Units (Becquerels to Curies)
Appendix B-2: Radioactivity conversion table for International System (SI) Units (Curies to Becquerels)
Appendix C-1: Technetium-99m decay and generation tables
Appendix C-2: Other radionuclide decay tables
Appendix D: Injection techniques and pediatric dosages
Appendix E-1: Sample techniques for nuclear imaging
Appendix E-2: Abnormal radio pharmaceutical distribution as a result of medications and other extrinsic factors
Appendix F: Nonradioactive pharmaceuticals in nuclear medicine
Appendix G: Pregnancy and breastfeeding
Appendix H-1: General considerations for hospitalized patients receiving radionuclide therapy
Appendix H-2: Special considerations and requirements for iodine-131 therapy
Appendix I: Emergency procedures for spills of radioactive materials.